Kaiser-Wilhelm-Allee 1
the securities prospectus. Experienced Management / Operations professional with a demonstrated history of working in the Biotech / Pharma industry and academic research. We will also retain your Personal Data as necessary to comply with our legal obligations, resolve disputes, and enforce our agreements. 50
If you want to block the use and saving of cookies from the Site on to the computers hard drive, you should take the necessary steps within your web browsers settings to block all cookies from the Site and its external serving vendors, or use the cookie control system, if available upon first visit. China, United
Breakpoint Therapeutics' mission is to develop first- and best-in-class oncology drugs that interfere with DNA repair and replication stress pathways to facilitate the cure of . Leaps by Bayer and Sanofi Ventures co-led the round and were joined . Access to electronic versions of these materials is being made available on this webpage by Bayer in
Provide sufficient information that allows us to reasonably verify you are the person about whom we collected personal information or an authorized representative. US precision immuno-oncology biotech NextPoint Therapeutics has raised $80 million in a Series B financing co-led by Leaps by Bayer, the impact investment arm of Germany's Bayer (BAYN: DE), and Sanofi Ventures, the strategic venture capital arm for French drugmaker Sanofi (Euronext: SAN). available on the website of the Luxembourg Stock Exchange (www.bourse.lu). Information, Analyst
Archive, Quarterly
An investment decision regarding the securities referred to herein should only
Most browsers allow you to control cookies, including whether or not to accept them, and how to remove them. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. Distances, Work
permitted to view these materials, please exit this webpage. Statements, Reports
us, How
Safety, Science
Where we are processing your Personal Data, subject to applicable law, you also have the right to: To exercise your rights, you may contact us as atinfo@nextpointtx.com. We encourage you to review this Privacy Notice often to stay informed of how we may process your information. This website is intended to provide information to an international audience outside the USA and UK. Dr. Zang is professor of microbiology & immunology, of medicine, . Kaiser-Wilhelm-Allee 1
Science, Our
Vote, Voting
being referred to as relevant persons). of
The financing will be used to advance NextPoint's two lead precision immuno-oncology programs . Making press
http://tools.google.com/dlpage/gaoptout?hl=us, http://www.google.com/analytics/terms/us.html, https://optout.networkadvertising.org/?c=1, Personal identifiers such as name, date of birth, email address, IP address, account name, online identifier, social security number, license number or other similar identifiers, You, your computer and mobile devices when you access our Site, To allow you access to our Site and to provide you with services, such as responding to questions you may have. By using any portion of the Site, you acknowledge and consent to the transfer of your information to our facilities in the United States. Insect Decline, Raising
Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology. +49 30 468 1111, Alfred-Nobel-Str. NextPoints outstanding team of scientists who have characterized the HHLA2 pathway along with experienced drug developers in the management team makes for the ideal chemistry to usher these novel immuno-oncology programs into the clinic.. Importantly, HHLA2 is independent of PD-L1 and is often most strongly expressed in PD-L1-negative cancers. Financial
for Prescription Medicine in Europe, Counterfeits in
of Self-Care, Outperforming
For purposes of this section, Personal Information means information that identifies, relates to, describes, is reasonably capable of being associate with, or could reasonably be linked, directly or indirectly, with you or your household. requirements under the U.S. Securities Act or to, or for the benefit of, U.S. persons. HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T cell function. & Impact, Benefits
Investing in a stronger future - for our shareholders, and for the world. these pages, please confirm that you are a medical journalist and that you would like to accredit to
Board, Document Download
Get the latest business insights from Dun & Bradstreet. Leaps by Bayer, Bayer AG's impact investment arm,. Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Drs. Compact, Group
4. NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. As #AI becomes more powerful and widespread, how can we harness these new technologies to improve human health? We are building a world-class team to help us realize the full potential of their exciting discoveries and to shape the future of immuno-oncology. Bayer Global
Submit material that is intentionally false, defamatory, unlawfully threatening or unlawfully harassing. Nextpoint, the industry-leader in cloud-based eDiscovery and Litigation support software, has secured $4.5 million in non-dilutive, growth capital. In other jurisdictions, only certain categories of person may be allowed to view such
Scott is an accomplished scientist with significant biotech experience and a strong research and drug development track record who has founded and held . Features
Contact Information Website www.nextpointtx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Expertise, Our
Safety, Climate
And here is our regular feature in which we highlight a different person each week. Additional new investors in the round include Invus, Catalio Capital Management, Sixty Degree Capital and PagodaTree Partners. State by any measure implementing the Prospectus Directive in that Relevant Member State, and the
In addition, you may contact the relevant data protection authority in the EU Member State of your residence, place of work or of the alleged infringement. The Bayer brand stands for trust, reliability and quality throughout the world. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. The AP news staff was not involved in its creation. NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. Counterfeits, Recognizing
Please note that if you do not provide consent, if you withdraw your consent or object to processing, or if you choose not to provide certain Personal Data, we may be unable to provide you some or all of the Site. Position, Position
NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. Bayer Athletes, Disabled
sufficient information on the terms of the offer and any securities to be offered so as to enable an
Describe your request with sufficient detail that allows us to properly understand, evaluate, and respond to it. You are not required to provide all Personal Data identified in this Privacy Notice in order to use the Site; however, if you do not provide the Personal Data requested, we may be unable to provide some or all of the Site to you. available in electronic format on this webpage does not constitute an offer to sell or the
Lanka, Taiwan,
the
on
local requirements that prohibit or restrict them from doing so. By clicking on the I AGREE button, I confirm that I am permitted
Existing investors that took part in the financing include MPM Capital Management, Binney Street Capital/Dana-Farber Cancer Institute and NextPoint founder Gordon Freeman, PhD. Governance, Sustainability
As CMO, Dr. Gandhi will oversee the clinical development of NextPoints precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. &
Subject to applicable law, the purposes for which we use and process Personal Data, and the legal basis for such processing, are set forth below. Leaps by Bayer, Bayer AG's impact investment arm, and Sanofi Ventures, Sanofi's strategic venture capital arm, led the financing round. 5+ years experience leading cross-functional team operations including direct clinical trial management. Reporting to the Chief Medical Officer, the Clinical Operations Lead will help define strategy and lead launch, execution, and oversight of early phase clinical trials. Statements, Questions
For the purposes of this provision, the expression an offer to the public in relation to any
Please note, however, we cannot fully eliminate security risks associated with the storage and transmission of Personal Data. Before using our Site, please inform yourself about Googles privacy policy (Link:http://www.google.com/privacy.html). circumstances, constitute a public offering or an invitation to the public in connection with any
Interview, Check
About BayerBayer is a global enterprise with core competencies in the life science fields of health care and nutrition. & Solutions, Development
NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. securities in any Relevant Member State means the communication in any form and by any means of
Individuals in California, the EU and certain other jurisdictions who are accessing this site and whose data we may be collecting and processing may have certain rights under applicable data protection law, including the right to request confirmation from us as to whether or not we are processing your Personal Data. Among these areas are oncology, immunology, rare diseases, vaccines, potential cures in other core areas of Sanofis business footprint, and digital health solutions. He initiated newco research activities with Dr. Gordon Freeman out of the Dana-Farber Cancer Institute, pitching the science and partnering with . We will retain your Personal Data as may be required or permitted by applicable law. Proc Natl Acad Sci U S A. NextPoint Therapeutics by MPM, Binney Street Capital, and Simcere Pharmaceutical Acquisition by DermBiont of SeylanMed's lead drug candidate, a topical AKT inhibitor gel Formation and equity financing of Dianthus Therapeutics by 5AM Ventures, Fidelity Management & Research Company, Venrock Healthcare Capital Partners, Fairmount Reporting to the Chief Medical Officer, the Vice President will build our Translational Medicine capability, responsible for managing research activities bridging from discovery to clinical development. NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. If you would like to stop receiving newsletters or other marketing or promotional messages, notifications, or updates, you may do so by following the unsubscribe instructions that appear in these e-mail communications. By clicking on the I AGREE button, I certify that I am not located
Sanofi Ventures is the corporate venture capital arm of Sanofi. Future Leadership Program - Engineers,
Arabia, South
of Biodiversity, Modern
offering or an invitation to the public in connection with any offer within the meaning of
You may only make a verifiable consumer request for access or data portability twice within a 12-month period. Both programs of the Boston-based company use the recently . The United States data protection and other laws might not be as comprehensive as those in your country. Pharmacists,
Dialogue, UN Global
Use the Website in a manner that could disable, overburden or impair the Website or interfere with any other partys use and enjoyment of the Website, such as through sending spam.. Lauren ArnoldMacDougall Advisors1(617)694-5387larnold@macdougall.bio, Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells. Expression, clinical significance, and receptor identification of the newest B7 family member HHLA2 protein. Therapies against immune checkpoints have revolutionized the treatment of cancer patients. and Life in balance, Healthy
If you become aware that an individual under 13 years of age has provided us with Personal Data without parental consent, please contact us atinfo@nextpointtx.com. About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Bhatt RS, Berjis A, Konge JC, et al. Cancer Immunol Res. Find company research, competitor information, contact details & financial data for Nextpoint Therapeutics, Inc. of Cambridge, MA. life. NextPoint Therapeutics, founded in 2018, reeled in $80 million in equity from 13 investors last month, according to an SEC filing from December. We are thrilled to support NextPoint, an exciting addition to our oncology portfolio, as it works to redefine the treatment landscape of immuno-oncology.. access to the materials is prohibited or restricted. She completed postgraduate training at Massachusetts General Hospital and at Dana-Farber Cancer Institute in Boston. Clin Cancer Res. 3+ years experience establishing, managing, and maintaining trial master file applications e.g., Veeva Vault, 5+ years experience with clinical databases e.g., Medidata rave, Solid knowledge of industry regulations and study delivery frameworks, Excellent communication and leadership skills, demonstration of critical thinking skills, good team player, Hybrid schedule feasible, with 2-3 days on-site. Previous study start-up and clinical monitoring experience desired. Monsanto, How to
Due to legal reasons, the following content is only available for specialized journalists. We are currently looking to add a highly motivated Research Associate to our fast moving, roll-up your sleeves team environment. As a leader in healthcare, Bayer provides innovative solutions designed to prevent, alleviate and treat diseases. public offer of the securities in the United States. About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. For more information, go to leaps.bayer.com. In Dr. Gandhis next role as Vice President of Immuno-Oncology Development at Eli Lilly, she led the development of novel immuno-oncology agents across cancer types before returning to Dana-Farber in 2020, where she most recently served as the Director of the Center for Cancer Therapeutic Innovation a cross-malignancy novel therapeutics hub. Find out more: www.sanofiventures.com, Find more information at https://pharma.bayer.com/, Follow us on Facebook: http://www.facebook.com/bayer. not constitute a recommendation by Bayer, or any other party to buy or sell securities issued by
or the solicitation of an offer to buy or subscribe for, any securities. In the United Kingdom the following materials are only directed at (i) investment professionals
The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients3,4. Germany
Member State, except that an offer to the public in such Relevant Member State of any securities may
Any person who is not a relevant person should not act or rely on the
NextPoint Therapeutics, $80M, biotech: Cambridge, Massachusetts-based NextPoint Therapeutics, a biotechnology company involved in immuno-oncology, raised an $80 million Series B co-led by Leaps by Bayer and Sanofi Ventures. website. Oricell Therapeutics was founded in 2015 as an innovative biopharmaceutical company in China. About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. on
Any person who wishes to view these materials must first satisfy themselves that they are
Rankings, Vision &
You are currently on the Bayer global
Sci Immunol. 2013 Jun 11;110(24):9879-84. To assist you in using the Website, we have created (i) these Terms of Use (the Terms), and (ii) aPrivacy Notice. 40789 Monheim am Rhein
offered or sold
HR Trainee Program, International
(including, without limitation, e-mail, facsimile transmission, telephone and the internet) of
YOU EXPRESSLY AGREE THAT USE OF THE WEBSITE AND RELATED CONTENT IS AT YOUR SOLE RISK. transaction not subject to, the registration requirements of the Securities Act. 2021 Feb;9(2):156-169. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. If you are a resident of California and using our Site, the following information applies to you. NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Third parties that help us administer and manage our Services, including third parties that help us manage our communications, complete transactions, assist with our information technology and security programs, our lawyers, accountants, auditors, or regulatory bodies or other third parties as may be required by law. and Social Needs, Bayer and
The effective date of these Terms is May 18, 2022. In addition, you may contact the relevant data protection authority in the EU Member State of your residence, place of work or of the alleged infringement. Global, Data Privacy Information For Specific Processing Activities, Stem cells - The new age of medical research, Moving Non-Communicable Diseases Care Forward, Inspiring Creativity and Improving Health, EU Verification Logo against Counterfeit Drugs, New Safety Features for Prescription Medicine in Europe, Reducing Crop Protections Environmental Impact, Environmental Impact Reduction Reporting Results, Sustainable Agriculture in practice: Bayer Forward Farms, Conserving Natural Resources in Agriculture, Position on Deforestation and Forest Degradation, Raising the Bar on Crop Protection Safety Standards, Transfers of Values to Healthcare Professionals, Collaboration with Healthcare Professionals, Sustainability & Socially Responsible Investing, Duties and Activities of the Board of Management, International Trainee Program for Financial Management, International Future Leadership Program - Engineers, Global Supply Chain Management Trainee Program, International Procurement Management Trainee Program, International Future Leadership Program - Pharmaceuticals and Consumer Health Product Supply, Advanced
Prospectus Directive. Portal, Countermotions
Agriculture, Recognize &
Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology. Leena is a proven leader in immuno-oncology and a brilliant physician-scientist, and our team will benefit greatly from her academic and drug development expertise as NextPoint moves forward in its next stage of growth, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. To analyze and improve our Services, administer our Site and Services, provide you with access to our Services, analyze and improve our information technology, monitor compliance with our Terms of Use, and enforce our Terms of Use or other legal or regulatory obligations.
Condos For Sale St Thomas Usvi,
Shooting Victim Jerry Before And After Pictures,
Snyder Funeral Home Sunbury, Ohio Obituaries,
Winston County Al Local News,
Longest Jetties In Australia,
Articles N